Tier 6
Diagnostics & IVDs
Indicative CAPEX
$10M – $50M
Market position
~99%
currently imported
Roughly 99% of in-vitro diagnostics used in Tanzania are imported, and regional demand is growing with every laboratory network expansion. The 35-acre Diagnostics zone (Zone C) and the 10-acre Lab Complex (Zone D) offer ready infrastructure for reagent, kit, and instrument assembly plants. IVD investors benefit from the same duty exemptions and TMDA fast-track as pharmaceutical manufacturers.
Why this tier
- Approximately 99% of IVDs currently imported
- Dedicated Diagnostics zone plus Lab Complex infrastructure
- Same duty exemptions and fast-track as pharma manufacturers
Next steps
Review the regulatory pathway · See the incentive package
Submit EOI for this tier